ketoconazole has been researched along with anandamide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ekins, S; Harwood, HJ; Hoover, DJ; Lawton, MP; Mankowski, DC; Treadway, JL | 1 |
| Björklund, E; Fowler, CJ; Jacobsson, SO; Larsson, TN | 1 |
2 other study(ies) available for ketoconazole and anandamide
| Article | Year |
|---|---|
Three-dimensional quantitative structure-activity relationship analysis of human CYP51 inhibitors.
Topics: Amides; Cytochrome P-450 Enzyme Inhibitors; Enzyme Inhibitors; Humans; Indoles; Models, Molecular; Oxidoreductases; Quantitative Structure-Activity Relationship; Sterol 14-Demethylase | 2007 |
Ketoconazole inhibits the cellular uptake of anandamide via inhibition of FAAH at pharmacologically relevant concentrations.
Topics: Amidohydrolases; Analysis of Variance; Arachidonic Acids; Caco-2 Cells; Dose-Response Relationship, Drug; Endocannabinoids; Hep G2 Cells; Humans; Ketoconazole; Polyunsaturated Alkamides; Receptor, Cannabinoid, CB2 | 2014 |